CYP2C9 and chronic kidney disease: Furthermore, members of the CYP2C subfamily, including CYP2C9, catalyze the oxidation of arachidonic acid to HETEs and EETs, promoting vasodilation and lowering blood pressure, which may play a role in the pathogenesis of chronic kidney disease (CKD) [24].